Works matching AU Chen, Hanrui

Results: 15

Prediction of the effect of Bupleurum chinensis DC. (Chaihu) on survival and its potential targets in hepatocellular carcinoma based on a prognostic model.

Published in:

BMC Complementary Medicine & Therapies, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12906-025-04848-4

By:

Li, Hanhan;
Liu, Shan;
Xiang, Shang;
Guo, Wei;
Huang, Jiayang;
Yu, Ling;
Chen, Zhuangzhong;
lin, Yuan;
Lin, Lizhu;
Chen, Hanrui

Publication type:

Article

Efficacy of Osimertinib in NSCLC Harboring Uncommon EGFR L861Q and Concurrent Mutations: Case Report and Literature Review.

Published in:

Frontiers in Oncology, 2021, v. 12, p. 1, doi. 10.3389/fonc.2021.731572

By:

Lin, Ruiting;
Chen, Ruilian;
Chen, Zhiqiang;
Hu, Leihao;
Guo, Wei;
Zhang, Zexin;
Lin, Lizhu;
Chen, Hanrui

Publication type:

Article

Network Pharmacology/Metabolomics-Based Validation of AMPK and PI3K/AKT Signaling Pathway as a Central Role of Shengqi Fuzheng Injection Regulation of Mitochondrial Dysfunction in Cancer-Related Fatigue.

Published in:

Oxidative Medicine & Cellular Longevity, 2021, p. 1, doi. 10.1155/2021/5556212

By:

Guo, Wei;
Liu, Shan;
Zheng, Xinting;
Xiao, Zhiwei;
Chen, Hanrui;
Sun, Lingling;
Zhang, Chi;
Wang, Zhijie;
Lin, Lizhu

Publication type:

Article

Immunotherapy as a neoadjuvant preoperative treatment for locally advanced pulmonary sarcomatoid carcinoma: a case report of clinical efficacy.

Published in:

2025

By:

Li, Hanhan;
Chen, Ruilian;
Guo, Wei;
Xiang, Shang;
Huang, Jiayang;
Chen, Hanrui

Publication type:

Case Study

A refractory case of CDK4-amplified spinal astrocytoma achieving complete response upon treatment with a Palbociclib-based regimen:a case report.

Published in:

2020

By:

Lin, Jietao;
Yu, Ling;
Fu, Yuanfeng;
Chen, Hanrui;
Zheng, Xinting;
Wang, Shutang;
Gao, Chan;
Cao, Yang;
Lin, Lizhu

Publication type:

journal article

Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling Pathway.

Published in:

Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01732

By:

Liao, Xiaozhong;
Tao, Lanting;
Guo, Wei;
Wu, Zhuo-Xun;
Du, Haiyan;
Wang, Jing;
Zhang, Jue;
Chen, Hanrui;
Chen, Zhe-Sheng;
Lin, Lizhu;
Sun, Lingling

Publication type:

Article

Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multicenter, Prospective Registry (NSCLCChinese and Western Integrative Medicine cohort).

Published in:

Integrative Cancer Therapies, 2023, v. 22, p. 1, doi. 10.1177/15347354231185109

By:

Lin, Jietao;
Sun, Lingling;
Chen, Hanrui;
Chen, Wenmin;
Zhang, Zexin;
Cao, Yang;
Lin, Lizhu

Publication type:

Article

Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study.

Published in:

Integrative Cancer Therapies, 2023, v. 22, p. 1, doi. 10.1177/15347354221151147

By:

Chen, Wenmin;
Lin, Jietao;
Yang, Ting;
xin Zhang, Ze;
Tao, Lanting;
Xiao, Zhiwei;
Chen, Hanrui;
Qi, Xiangjun;
Sun, Lingling;
Cao, Yang;
Lin, Lizhu

Publication type:

Article

Sunitinib-and-Chinese herbal medicine-based systematic treatment clinically cured a patient with multiple metastatic primary clear cell carcinoma of the liver: a case report.

Published in:

OncoTargets & Therapy, 2019, v. 12, p. 2823, doi. 10.2147/OTT.S197923

By:

Sun, Lingling;
Chen, Hanrui;
Xiao, Zhiwei;
Guo, Wei;
Lin, Lizhu

Publication type:

Article

Transcriptomic sequencing analysis of key long noncoding RNAs and mRNAs expression profiles in postoperative recurrence of hepatocellular carcinoma.

Published in:

Technology & Health Care, 2024, v. 32, n. 2, p. 735, doi. 10.3233/THC-230123

By:

Yao, Xiaohui;
Liu, Shan;
Xia, Huan;
Li, Hanhan;
Wang, Zhijie;
Su, Le;
Guo, Wei;
Chen, Hanrui

Publication type:

Article

DLC2 operates as a tumor suppressor gene in breast cancer via the RhoGTPase pathway.

Published in:

Oncology Letters, 2019, v. 17, n. 2, p. 2107

By:

Yang, Zheng;
Chen, Hanrui;
Shu, Man;
Zhang, Yunjian;
Xue, Ling;
Lin, Yuan

Publication type:

Article

Case Report: Clinical benefit from multi-target tyrosine kinase inhibitor and PARP inhibitor in a patient with cancer of unknown primary with BRCA1 large genomic rearrangement.

Published in:

Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.997760

By:

Ling Yu;
Jietao Lin;
Hanhan Li;
Lingling Sun;
Shubo Wang;
Yaoxu Chen;
Hanrui Chen;
Lizhu Lin

Publication type:

Article

Posterior reversible encephalopathy syndrome associated with use of anlotinib to treat squamous cell carcinoma of the cervix: case report and literature review.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1255785

By:

Jietao Lin;
Wenmin Chen;
Sha Zhong;
Kai Qian;
Hanrui Chen;
Lizhu Lin

Publication type:

Article

ECFuse: Edge-Consistent and Correlation-Driven Fusion Framework for Infrared and Visible Image Fusion.

Published in:

Sensors (14248220), 2023, v. 23, n. 19, p. 8071, doi. 10.3390/s23198071

By:

Chen, Hanrui;
Deng, Lei;
Zhu, Lianqing;
Dong, Mingli

Publication type:

Article

Shenqi Fuzheng injection facilitates skeletal muscle mitophagy mediated by the ubiquitination of HIF‐1α to ameliorate cancer‐associated fatigue.

Published in:

Journal of Cellular & Molecular Medicine, 2024, v. 28, n. 12, p. 1, doi. 10.1111/jcmm.18455

By:

Guo, Wei;
Liu, Shan;
Xia, Huan;
Luo, Jiamin;
Chen, Hanrui;
Hu, Leihao;
Zheng, Xinting;
Xiao, Zhiwei;
Lin, Lizhu

Publication type:

Article